Aligos therapeutics to announce third quarter results november 2, 2022

South san francisco, calif., oct. 19, 2022 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs, the “company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the company's third quarter 2022 financial results on wednesday, november 2, 2022 after the close of the u.s. financial markets.
ALGS Ratings Summary
ALGS Quant Ranking